EcoVadis and SE Advisory Collaborate to Decarbonise Pharma Value Chains

Healthcare supply chain programme links EcoVadis ratings with renewable energy support

EcoVadis and SE Advisory Services have joined forces to help pharmaceutical suppliers access renewable energy guidance and carbon reduction support. The partnership connects suppliers already part of EcoVadis’s Responsible Health Initiative with Schneider Electric’s Energize programme. This creates a direct pathway from sustainability assessment to practical decarbonisation action.

The arrangement combines EcoVadis’s supplier rating platform with SE Advisory Services’ technical expertise in renewable energy procurement and carbon management. Suppliers can now move from assessment to implementation with access to training, personalised guidance, and carbon reporting tools. For healthcare companies trying to reduce emissions across their supply chains, this represents a structured approach to a problem that has proved difficult to solve through procurement pressure alone.

Supply chain emissions account for the vast majority of carbon footprints in pharmaceutical and medical device manufacturing. Consequently, companies cannot meet net zero commitments without addressing supplier emissions. However, many suppliers lack the resources or expertise to make meaningful progress on renewable energy. This programme attempts to bridge that gap by providing coordinated support at scale.

Major pharmaceutical companies including GSK, Teva, and Takeda are backing the broader Responsible Health Initiative. Their involvement signals growing recognition that supply chain decarbonisation requires collaborative infrastructure rather than isolated supplier mandates. Suppliers participating in the initiative can now access Energize programme support as part of their engagement with these healthcare buyers.

Responsible Health Initiative creates shared sustainability infrastructure

EcoVadis launched the Responsible Health Initiative to improve visibility and sustainability performance across global health supply chains. The initiative uses EcoVadis’s assessment methodology to evaluate supplier practices on environmental and social criteria. Participating suppliers receive ratings that help healthcare buyers understand sustainability performance across their procurement base.

The initiative goes beyond assessment by creating a structured engagement framework. Suppliers work through improvement programmes based on their rating results. Healthcare companies gain comparable data across their supplier networks. This creates a common language for sustainability performance that was previously absent from pharmaceutical procurement.

The Energize collaboration adds a practical dimension to this assessment framework. Suppliers identified through EcoVadis ratings can now access specific support for renewable energy adoption. SE Advisory Services provides technical guidance on renewable energy procurement options, contract structures, and carbon accounting. This moves suppliers from awareness to action on what is often the single largest opportunity for emissions reduction.

Fernanda Campos Helmeister from SE Advisory Services described the partnership as making renewable energy adoption more accessible across different geographies. This matters because pharmaceutical supply chains are genuinely global. Suppliers operate under different regulatory frameworks, energy markets, and renewable energy availability. A supplier in India faces different challenges and opportunities compared to one in Germany or Mexico. The programme aims to provide relevant guidance regardless of location.

EcoVadis positions the collaboration as bringing together healthcare leaders, suppliers, and sustainability experts to address Scope 3 emissions challenges. Scope 3 refers to emissions that occur in a company’s value chain but outside its direct control. For pharmaceutical companies, these emissions typically dwarf those from their own operations. Therefore, supply chain decarbonisation becomes essential rather than optional for credible climate commitments.

Renewable energy adoption targeted as primary decarbonisation lever

The programme emphasizes renewable energy as the main mechanism for supplier emissions reduction. This reflects the reality that electricity consumption represents a significant portion of manufacturing emissions for many pharmaceutical suppliers. Switching to renewable electricity can therefore deliver substantial carbon reductions relatively quickly compared to process changes or material substitution.

Suppliers joining the Energize programme receive support on several fronts. Training covers the basics of renewable energy procurement and the different mechanisms available in various markets. Personalised guidance helps suppliers evaluate options relevant to their specific operations and locations. Carbon management support enables suppliers to measure and report on emissions reductions accurately.

This structured approach addresses a common barrier to supplier action. Many small and medium suppliers want to reduce emissions but lack internal expertise on renewable energy markets. They may not understand the difference between unbundled renewable energy certificates, power purchase agreements, and on-site generation. Furthermore, they may struggle to assess which options are financially viable for their business. The programme provides this expertise without requiring suppliers to build it internally.

For healthcare buyers, the programme offers a way to support suppliers without directly funding their energy transitions. Instead of subsiding renewable energy purchases, buyers facilitate access to expertise and tools. This makes the model more scalable than direct financial support. It also places responsibility for action with suppliers while providing the resources they need to act.

The focus on renewable energy aligns with broader corporate climate strategies. Most science-based targets now require absolute emissions reductions rather than intensity improvements. Renewable energy procurement delivers these absolute reductions in a way that is measurable and verifiable. It also fits within existing business operations without requiring fundamental changes to products or processes.

Programme structure combines assessment, engagement, and technical support

The partnership creates a clear progression for suppliers. First, companies undergo EcoVadis assessment as part of their engagement with healthcare buyers. This assessment identifies current sustainability performance and highlights improvement areas. Energy and emissions typically feature as key assessment criteria for manufacturing suppliers.

Second, suppliers with lower sustainability ratings or high emissions can access targeted support through the Energize programme. This support includes educational resources, guidance on renewable energy options, and assistance with carbon accounting. Suppliers can work at their own pace based on their capacity and circumstances. However, the programme structure provides a clear pathway rather than leaving suppliers to navigate decarbonisation alone.

Third, suppliers implement renewable energy solutions with ongoing support from SE Advisory Services. This might involve signing power purchase agreements, installing on-site solar generation, or purchasing renewable energy certificates depending on location and circumstances. The programme helps suppliers understand trade-offs between different options and select appropriate solutions.

Fourth, suppliers report on their progress through EcoVadis’s platform. This creates transparency for healthcare buyers and demonstrates improvement over time. It also generates data that can feed into buyer Scope 3 emissions calculations and sustainability reporting. The reporting component closes the loop between assessment, action, and verification.

This integrated approach distinguishes the programme from isolated initiatives. Many suppliers face multiple sustainability assessment requests from different buyers. These assessments often overlap but use different methodologies and platforms. The Responsible Health Initiative creates a shared framework that multiple buyers recognize. Adding Energize support on top of this shared framework makes the model more efficient for suppliers.

Five key facts about the EcoVadis and Energize collaboration

• The partnership connects suppliers in the Responsible Health Initiative with renewable energy support through Schneider Electric’s Energize programme.
• Major pharmaceutical companies including GSK, Teva, and Takeda participate in the Responsible Health Initiative and support this supplier engagement model.
• The programme focuses specifically on Scope 3 emissions reduction, which represent the largest portion of pharmaceutical industry carbon footprints.
• Suppliers receive training, personalised guidance, and carbon management support to help them adopt renewable energy solutions appropriate to their locations.
• The collaboration aims to make renewable energy adoption accessible across different geographies within global pharmaceutical supply chains.

What this means for UK suppliers to pharmaceutical companies

If you supply pharmaceutical or healthcare companies that participate in the Responsible Health Initiative, you may be asked to complete an EcoVadis assessment if you have not already done so. This assessment evaluates environmental, social, and governance practices including energy use and carbon emissions. Your results will be visible to participating healthcare buyers and may influence procurement decisions.

For suppliers with significant electricity consumption, this programme creates an opportunity to access renewable energy expertise without bearing the full cost of consultancy support. Many UK manufacturers struggle with the complexity of renewable energy procurement. Options include private wire arrangements, sleeved power purchase agreements, and virtual power purchase agreements. Each option has different cost structures, contract terms, and risk profiles. The Energize programme can help you understand these options in the context of your specific operations.

You should also consider how this programme fits with UK carbon reporting requirements. If you meet the thresholds for Streamlined Energy and Carbon Reporting, you already report on energy consumption and emissions. Additionally, renewable energy procurement could help you demonstrate progress on carbon reduction in future reports. It may also strengthen your position when responding to tenders that include carbon reduction requirements or social value criteria.

For smaller suppliers, the programme represents a more accessible entry point to decarbonisation than developing internal expertise. Building internal capability on renewable energy markets, carbon accounting, and sustainability reporting requires time and resources. Many SMEs cannot justify dedicated sustainability staff. Accessing structured support through a buyer-backed programme reduces this barrier. It also provides credibility when discussing sustainability performance with current and prospective customers.

Bear in mind that participation in programmes like this may become an expectation rather than a differentiator. As more pharmaceutical companies adopt Scope 3 emissions targets, supplier engagement on carbon reduction will intensify. Early engagement demonstrates responsiveness to buyer requirements. It also gives you time to implement changes before they become mandatory procurement criteria. Waiting until carbon performance becomes a minimum threshold for supplier qualification leaves less room for manoeuvre.

UK suppliers should also watch for similar initiatives in other sectors. The pharmaceutical industry is not unique in facing Scope 3 emissions challenges. Manufacturing, automotive, electronics, and consumer goods sectors all grapple with supply chain decarbonisation. The model of combining assessment platforms with technical support programmes may spread to other industries. Building experience with this approach in healthcare supply chains could prepare you for similar requirements elsewhere.

Consider your renewable energy options and carbon reporting capability

If you are a pharmaceutical supplier, review your current energy procurement arrangements and carbon footprint. Understanding your baseline position helps you evaluate whether renewable energy makes commercial sense for your operations. Calculate what proportion of your emissions come from electricity consumption. If electricity represents a significant share, renewable procurement could deliver meaningful carbon reductions.

We support businesses with carbon reporting and ESG compliance requirements including Streamlined Energy and Carbon Reporting and carbon reduction planning. For suppliers facing sustainability assessments or carbon reduction requests from buyers, having accurate emissions data and a clear reduction plan strengthens your commercial position. Our net zero programme helps businesses develop credible carbon reduction strategies that align with buyer expectations and regulatory requirements.

Look at your exposure to PPN 06/21 if you tender for public sector contracts. This procurement policy notice requires suppliers bidding for central government contracts above certain thresholds to publish a carbon reduction plan. Many NHS trusts and health bodies now apply similar requirements. Renewable energy procurement forms part of most credible carbon reduction plans. Therefore, gaining experience with renewable energy now could support future tender responses across both private and public healthcare procurement.

Consider the commercial case for action beyond compliance. Some pharmaceutical companies now include carbon performance in supplier scorecards. This can affect contract renewals, preferred supplier status, and access to new opportunities. While sustainability performance alone rarely wins contracts, it increasingly features in supplier evaluation. Understanding renewable energy options and demonstrating progress on emissions reduction protects existing business relationships and supports new business development.

Training your procurement and operations teams on carbon and energy issues will become increasingly important. SBS Academy provides training on carbon literacy, Scope 3 emissions, and sustainable procurement for businesses that need to build internal capability. Even if you access external support through programmes like Energize, having internal knowledge helps you ask the right questions and make informed decisions about energy procurement and carbon reduction.

Further information and official sources

For details on the Responsible Health Initiative and EcoVadis’s approach to supply chain sustainability, visit the EcoVadis website. The platform provides information on assessment methodology, industry initiatives, and supplier resources.

The Schneider Electric website includes information about the Energize programme and renewable energy solutions for businesses. SE Advisory Services operates as part of Schneider Electric’s sustainability business.

UK businesses should review government guidance on Streamlined Energy and Carbon Reporting to understand mandatory carbon reporting requirements. This guidance explains which companies must report and what information they must disclose.

For information on carbon reduction plans and public sector procurement requirements, see the government’s guidance on PPN 06/21. This policy note sets out requirements for suppliers bidding for central government contracts.

The UK government’s Net Zero Strategy provides broader context on national carbon reduction commitments and how these affect different sectors including healthcare and manufacturing.